Minerals Technologies Inc. develops, produces, and markets various mineral, mineral-based, and related systems and services. The company operates through two segments, Consumer & Specialties, and Engineered Solutions segments. The Consumer & Specialties segment offers household and personal care products, such as pet litter, personal care, fabric care, edible oil and renewable fluid purification, animal health, and agricultural products under the PREMIUM CHOICE, VitaLife, Sivocat, SIVO, RAFINOL, and ENERSOL brand names; and specialty additives products, including precipitated calcium carbonate and ground calcium carbonate products that are used in the paper, paperboard, and fiber-based packaging industries, as well as automotive, construction, consumer markets, and packaging applications. The Engineered Solutions segment provides high-temperature technology products consisting of custom-blended mineral and non-mineral products for casting auto and heavy truck parts, agriculture and construction equipment, municipal, infrastructure and other industrial castings; and environmental and infrastructure products comprising geosynthetic clay lining systems, vapor intrusion mitigation products, sub surface waterproofing systems, green roofs, wastewater remediation, drinking water purification technologies, and drilling products. In addition, this segment offers gunnable monolithic refractory products and application systems; monolithic refractory materials and pre-cast refractory shapes; refractory shapes and linings; carbon composites and pyrolitic graphite under PYROID brand; and filtration and well testing services. It markets its products primarily through its direct sales force, as well as regional distributors. The company operates in the United States, Canada, Latin America, Europe, Africa, and Asia. Minerals Technologies Inc. was incorporated in 1968 and is headquartered in New York, New York.

Minerals Technologies Inc.

MindMaze Therapeutics Holding SA ( ($CH:MMTX) ) has provided an update. MindMaze Therapeutics announced it will participate in a series of investor...

MindMaze to Spotlight Neurotherapeutics at Series of Global Investor and Industry Conferences

MindMaze Therapeutics Holding SA ( ($CH:MMTX) ) has provided an update. MindMaze Therapeutics reported its 2026 half-year results alongside a corpo...

MindMaze sharpens neurotherapeutics focus as losses widen in first half

Immatics ( ($IMTX) ) just unveiled an announcement. Immatics N.V., a Nasdaq-listed biotech company headquartered in Houston and Tübingen, focuses o...

Immatics Raises $161 Million in Completed Equity Offering to Advance PRAME Cancer Programs

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AEON Biopharma (AEON), BioMarin Pharmaceutical (BM...

Analysts Offer Insights on Healthcare Companies: AEON Biopharma (AEON), BioMarin Pharmaceutical (BMRN) and Immatics (IMTX)

In a report released today, Sam Burgess from Goldman Sachs maintained a Hold rating on MTU Aero Engines, with a price target of €380.00. According ...

Goldman Sachs Remains a Hold on MTU Aero Engines (0FC9)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioMarin Pharmaceutical (BMRN), Immatics (IMTX) and ...

Analysts’ Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Immatics (IMTX)

Berenberg Bank analyst George McWhirter maintained a Hold rating on MTU Aero Engines today and set a price target of €390.00. According to TipRanks...

Berenberg Bank Keeps Their Hold Rating on MTU Aero Engines (0FC9)

Jefferies analyst Chloe Lemarie maintained a Buy rating on MTU Aero Engines today and set a price target of €460.00. According to TipRanks, Lemarie...

Jefferies Sticks to Its Buy Rating for MTU Aero Engines (0FC9)

An announcement from RELIEF THERAPEUTICS Holding ( ($CH:MMTX) ) is now available. MindMaze Therapeutics Holding SA has appointed Prof. John W. Krak...

MindMaze Therapeutics Taps Leading Neuroscientist John Krakauer to Steer U.S. Growth

RELIEF THERAPEUTICS Holding ( ($CH:MMTX) ) has provided an update. MindMaze Therapeutics has completed an organizational simplification, shedding m...

MindMaze Streamlines to Core Neurology as Neuro.io Financing Advances

MTU Aero Engines received a Sell rating and a €420.00 price target from Barclays analyst Milene Kerner today. According to TipRanks, Kerner is a 5-...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MTX	$71.76	+1.28%	133.07K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MTX	$71.76	+1.3%	133.07K
3
4
5
6

MTX

Get Minerals Technologies Inc. Data in Excel

Get Minerals Technologies Inc. Data in Excel